AstraZeneca Plc is likely to conduct an additional global trial to assess the efficacy of its Covid-19 vaccine, according to the company’s chief executive, after current studies raised questions about its level of protection. The new trial would be conducted rather than adding an arm to an ongoing trial in …
Read More »Results of new phase 2 trial of Oxford covid-19 vaccine show success in older people
Written by Kaunain Sheriff M | New Delhi | Updated: November 20, 2020 9:52:14 am “Further evaluation of the efficacy of this vaccine is warranted in all age groups and individuals with comorbidities,” the researchers said. The Oxford-AstraZeneca Covid-19 candidate vaccine has triggered a robust immune response in older adults …
Read More »